Abbreviated Company Accounts - BIOPLAX LIMITED

Registered Number 05278706

BIOPLAX LIMITED

Abbreviated Accounts

31 December 2014

BIOPLAX LIMITED Registered Number 05278706

Abbreviated Balance Sheet as at 31 December 2014

	Notes	2014	2013
		€	€
Fixed assets
Intangible assets	2	8,165	10,887
Investments	3	-	99,000
		8,165	109,887
Current assets
Debtors		1,949,773	472,741
Investments		1,871,845	721,867
		3,821,618	1,194,608
Creditors: amounts falling due within one year		(1,327,636)	(527,028)
Net current assets (liabilities)		2,493,982	667,580
Total assets less current liabilities		2,502,147	777,467
Total net assets (liabilities)		2,502,147	777,467
Capital and reserves
Called up share capital		100,003	100,003
Profit and loss account		2,402,144	677,464
Shareholders' funds		2,502,147	777,467

For the year ending 31 December 2014 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 14 August 2015

And signed on their behalf by:
Marco Silvio Jaeggi, Director

BIOPLAX LIMITED Registered Number 05278706

Notes to the Abbreviated Accounts for the period ended 31 December 2014

1Accounting Policies

Basis of measurement and preparation of accounts
The accounts have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities effective April 2008.

Other accounting policies
Cash flow

The financial statements do not include a Cash flow statement because the company, as a small reporting entity, is exempt from the requirement to prepare such a statement under the Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover

Turnover comprises revenue recognised by the company in respect of goods and service supplied during the year, exclusive of Value Added Tax and trade discounts.

Intangible fixed assets and amortisation

Patents and trademarks - 25% - reducing balance method.

Foreign currencies

Monetary assets and liabilities denominated in foreign currencies are translated into Euro at rates of exchange ruling at the balance sheet date.
Transactions in foreign currencies are translated into Euro at the rate ruling on the date of the transaction.
Exchange gains and losses are recognised in the profit and loss account.

2Intangible fixed assets

	€
Cost
At 1 January 2014	145,000
Additions	-
Disposals	-
Revaluations	-
Transfers	-
At 31 December 2014	145,000
Amortisation
At 1 January 2014	134,113
Charge for the year	2,722
On disposals	-
At 31 December 2014	136,835
Net book values
At 31 December 2014	8,165
At 31 December 2013	10,887

The company holds a trade mark registered under the name of 'Aftamed' and a patent registered under the name of 'Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas'.

3Fixed assets Investments
The company used to hold 99% of the ordinary shares in Bioplax Italia Srl. During the year under review the shares were sold to Esperia Servizi Fiduciari SPA for €1,485,000. The funds reached the company's bank account on 13 March 2015.